Model
Edge
Five Prime Therapeutics, Inc.
0001329049
Filing Type
4
Filing Date
2/25/2020
Updated
2/26/20, 1:13 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership